Trade Ideas August 18, 2026 07:17 AM

Buy the Reset: monday.com Workforce Cuts Create a Cleaner Path to Profit Growth

Cost takeout plus solid revenue momentum makes a mid-term long with defined risk-reward attractive

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
MNDY

monday.com's recent workforce reduction is a tactical reset that should materially improve operating leverage, reduce future dilution pressure, and support higher free cash flow. With revenue growth still in the mid-20s, a sub-$90 entry offers a favorable risk-reward into improving margins and improving enterprise traction.

Buy the Reset: monday.com Workforce Cuts Create a Cleaner Path to Profit Growth
MNDY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Workforce reduction materially reduces fixed costs and lowers dilution risk
  • Revenue growth remains in the mid-20s with run-rate above $1.2B and guidance near $1.47B
  • Market cap ~$3.52B with P/E ~37x; margin expansion can justify multiple recovery
  • Entry at $84.26, stop $72.00, target $110.00; mid-term horizon (45 trading days)

Hook & thesis

monday.com is executing a painful but logical reset: a workforce reduction to remove costs and sharpen focus on enterprise customers. That action, combined with recurring revenue growth in the mid-20s and $100M+ quarterly operating cash flow reported by investors, sets the stage for faster profit expansion and less need for equity dilution. The market has punished the stock deeply this year; at todays price of $84.26 the risk-reward for a defined mid-term trade looks attractive.

My trade idea: take a long position around $84.26 with a clear stop below the nearest structural support and a profit target that prices in multiple expansion as profitability accelerates and short interest cools. The setup is not a return-to-growth story alone - its a margin and cash-flow cleanup that can change investor sentiment.

What monday.com does and why investors should care

monday.com operates a cloud-based visual work operating system that businesses use to build workflow apps and coordinate work across teams. Its modular platform integrates with other enterprise tools and has been expanding into higher-value enterprise accounts. Investors care because the business is subscription-based: revenue is recurring, gross margins on cloud-native SaaS can be high, and incremental revenue tends to flow straight to the bottom line as fixed costs are absorbed.

Recent fundamentals - the numbers that matter

  • Revenue momentum: public reporting and analyst summaries show year-over-year revenue growth in the mid-20s (multiple items note ~22%-26% YoY), with quarterly revenue figures in the $300M+ range and annual run-rates above $1.2B. Management raised full-year revenue guidance to roughly $1.47B as part of a recent update.
  • Profit and cash flow: the company has moved from a cash-burn story toward positive operating leverage, with investors citing >$100M in quarterly operating cash flow and a doubling of operating income in recent periods.
  • Valuation and size: market capitalization is about $3.52B. The stock trades around a P/E of 37.3 today, and a P/S multiple nearer to the low single digits (stated comparisons put it around ~3x). That multiple reflects both durable recurring revenue and lingering concerns about AI disruption and growth deceleration.
  • Share base and float: shares outstanding are ~42.27M with a public float of ~32.2M, reducing the risk of massive unpriced dilution if management can fund growth from operating cash flow going forward.
  • Technicals and market structure: price sits under the 10-day SMA (~$89.31) but above the 50-day SMA (~$81.06) and the 50-day EMA (~$82.81), suggesting consolidation with a slight bullish bias. RSI near 48 is neutral. Short interest has been elevated across the year but dropped to ~4.7M as of 07/31/2026 with days-to-cover of ~2.5, which lowers the chance of disorderly squeeze dynamics but keeps a downside pressure element.

Why the workforce reduction matters

Headcount reductions are never popular, but for SaaS companies they have two direct benefits: they lower fixed operating costs (improving operating margins) and reduce the need for future equity raises if cash flow trends positive. With roughly 3,155 employees on the books, a targeted reduction can move the needle materially on non-R&D SG&A. The result should be faster improvement in net income and free cash flow while revenue continues at a mid-20s growth rate.

Valuation framing

At a market cap near $3.52B, investors are effectively paying for recurring revenue growth and the optionality of expanding into larger enterprise accounts. A P/E of 37x is not cheap, but if operating margins expand meaningfully (management has already demonstrated an ability to double operating income) and cash flow continues above $100M per quarter, multiple expansion back toward the sector median would be justified. Put differently: the stock currently prices a level of execution risk. The workforce cuts reduce that execution risk, which should compress the risk premium embedded in the multiple.

Catalysts

  • Margin rehabbing from the workforce reduction - the market will re-rate on visible quarterly margin expansion within 1-3 quarters.
  • Enterprise wins and expansion - the company reported a 74% increase in enterprise customers in recent commentary, and further expansion of large contracts would meaningfully boost ARR quality.
  • Guidance and cash flow updates - managements guidance raise to about $1.47B and continued $100M+ quarterly operating cash flow can act as a sentiment catalyst (noted by investors in May and June commentary).
  • Lower dilution risk - as operating cash flow rises and equity raises become less necessary, investors often reward SaaS companies with higher multiples.

Trade plan (actionable)

Direction: Long
Entry price: $84.26
Stop loss: $72.00
Target price: $110.00

Horizon: mid term (45 trading days). Rationale: the workforce reduction should show up in the next one to two reported quarters as improved operating margins and cash flow. Fifty trading days is too long for this catalyst window; 45 trading days gives time for at least one quarterly update or material intra-quarter commentary while keeping position size and risk managerially sensible.

Risk management: size the position so that a drop from entry to stop ($84.26 to $72.00) is an acceptable loss versus your portfolio. If price accelerates above the target on strong volume and margin beats, consider scaling out or moving stops to breakeven to lock in gains.

Why this trade has asymmetric upside

Upside comes from two converging forces: continued mid-20s revenue growth (which preserves top-line momentum) and a faster path to profitability driven by cost cuts and operating leverage. At current float levels (~32.2M) and with short-interest declining, a visible margin-improvement print could attract contrarian buyers and funds looking for improving cash flows without immediate dilution risk.

Risks and counterarguments

  • AI disruption is real. Critics argue that AI coding agents could automate parts of monday.coms platform or make low-code workflow tools less sticky. If AI materially reduces customer retention or contract sizes, revenue growth could slow faster than expected.
  • Execution risk on integration and product-led growth. Cutting headcount might accelerate margins but can also slow product development and client support, hurting net retention if not carefully managed.
  • Valuation complacency. A P/E near 37x implies continued execution; a single missed quarter or conservative guidance could re-open a large downside since the multiple is still premised on profitable growth.
  • Macro and SaaS multiple sensitivity. SaaS stocks remain sensitive to rising rates and multiples can compress quickly if risk appetite evaporates again.
  • Market structure risk: elevated short-volume in recent days shows the stock can experience rapid, volatile moves on news flow. That increases the chance the stop is tested.

Counterargument

One could argue this is still a growth-at-any-cost story and that workforce cuts are a short-term fix that wont address secular pressures from AI or increased competition. If growth meaningfully decelerates below the mid-20s and enterprise expansion stalls, multiple contraction could overwhelm any margin gains, making this a value trap rather than a turnaround.

What would change my mind

I would reconsider the long stance if any of the following occurs: revenue growth decelerates to low single digits YoY, net retention rolls over materially, or management signals the workforce reduction will materially impede product roadmaps and customer success. Conversely, I would add to the position if the company reports a quarter showing >100 basis points of sequential operating margin improvement and reiterates or raises guidance, or if cash flow sustainably exceeds $100M per quarter while ARR growth stays in the 20%-plus range.

Conclusion

monday.coms workforce reduction is a difficult but sensible step toward turning strong recurring revenue into durable profits and free cash flow. At $84.26, the stock prices a significant execution risk; the workforce cut materially reduces that risk. For traders comfortable with mid-term horizon bets, a defined long with a stop at $72.00 and a target of $110.00 provides a reasonable risk-reward to capture the likely rerating on better margins and lower dilution pressure.

Trade idea date: 08/18/2026 - Keep position size disciplined and watch the next quarterly update for margin trajectory.

Risks

  • AI-driven disruption could reduce product stickiness and slow growth materially
  • Headcount cuts risk slowing product development and customer success, hurting retention
  • High P/E means a single missed quarter could re-open a large downside
  • Elevated short-volume and prior volatility increase the chance of sharp intraday moves

More from Trade Ideas

Buy the Soft Spot, Not the Mainframe: A Tactical Long on IBM as Software Momentum Needs Time to Heal Aug 18, 2026 Meren Energy: Undervalued Income Play with Upside Optionality Aug 18, 2026 Why Precision BioSciences Could See a Meaningful Pop on Early HBV Editing Data Aug 18, 2026 Pfizer: High Yield and Solid Cash Flow but a Patent Cliff Looms — A Tactical Long Aug 18, 2026 Sandisk: Compelling Entry, But Only as a Tactical Long - Manage the Cycle Aug 18, 2026